BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $52,188,000 | +21.9% | 52,500,000 | +22.1% | 0.05% | +56.2% |
| Q1 2022 | $42,825,000 | -23.0% | 43,000,000 | -20.6% | 0.03% | -40.7% |
| Q1 2021 | $55,622,000 | +68.8% | 54,180,000 | +76.3% | 0.05% | +63.6% |
| Q4 2020 | $32,949,000 | +15.7% | 30,730,000 | +12.9% | 0.03% | 0.0% |
| Q3 2020 | $28,480,000 | -52.5% | 27,230,000 | -44.6% | 0.03% | -52.2% |
| Q2 2020 | $60,002,000 | +155.5% | 49,150,000 | +118.4% | 0.07% | +122.6% |
| Q1 2020 | $23,485,000 | -60.6% | 22,500,000 | -62.7% | 0.03% | -47.5% |
| Q3 2019 | $59,538,000 | -20.3% | 60,355,000 | -16.1% | 0.06% | -14.5% |
| Q2 2019 | $74,677,000 | +12.9% | 71,905,000 | +11.2% | 0.07% | +4.5% |
| Q1 2019 | $66,119,000 | -18.8% | 64,645,000 | -21.2% | 0.07% | -25.8% |
| Q4 2018 | $81,392,000 | +3.5% | 82,000,000 | +11.3% | 0.09% | +25.4% |
| Q3 2018 | $78,643,000 | +38.0% | 73,705,000 | +31.2% | 0.07% | +29.1% |
| Q2 2018 | $56,992,000 | +54.4% | 56,180,000 | +43.4% | 0.06% | +57.1% |
| Q1 2018 | $36,908,000 | -11.4% | 39,180,000 | -6.2% | 0.04% | +6.1% |
| Q4 2017 | $41,671,000 | +50.9% | 41,755,000 | +53.5% | 0.03% | +37.5% |
| Q3 2017 | $27,608,000 | – | 27,200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |